ライフサイエンスコーパス: right ventricular systolic pressure

1 on, LV end-diastolic dimension, LV mass, and right ventricular systolic pressure.

2 ted for approximately 60% of the increase in right ventricular systolic pressure.

3 ertrophy, pulmonary vascular remodeling, and right ventricular systolic pressure.

4 se PASMCs was correlated with an increase in right ventricular systolic pressure.

5 ere associated with reversible increments of right ventricular systolic pressure.

6 h-fat diet develop PAH as judged by elevated right ventricular systolic pressure.

7 aled NO, or intravenous iloprost in reducing right ventricular systolic pressure.

8 T gradient (51.4 to 21.7 mm Hg, P<0.001) and right ventricular systolic pressure (72.8 to 47.3 mm Hg,

9 monary hypertension, judged by regression of right ventricular systolic pressure and hypertrophy and

10 At 17 weeks postinfection, right ventricular systolic pressure and liver and lung e

11 asurements indicated modest increases in the right ventricular systolic pressure and right ventricle

12 atment significantly attenuated elevation of right ventricular systolic pressure and right ventricula

13 S100A4/Mts1 mice had greater right ventricular systolic pressure and right ventricula

14 (-/-) mice developed significantly increased right ventricular systolic pressure and substantial pulm

15 odel, A-17 treatment significantly decreased right ventricular systolic pressure and total pulmonary

16 The Tg(+) mice exhibited elevated right ventricular systolic pressures and right ventricul

17 tation, LV ejection fraction, LV dimensions, right ventricular systolic pressure) and exercise variab

18 In the PH mouse model, A-17 and A-21 reduced right ventricular systolic pressure, and all antagomirs

19 All rats developed pulmonary hypertension (right ventricular systolic pressure approximately 100 mm

20 had lower plasma adiponectin, and had higher right ventricular systolic pressure associated with righ

21 mice, sildenafil attenuated the increase in right ventricular systolic pressure but without a signif

22 ypertension ( approximately 118% increase in right ventricular systolic pressure) but not polycythemi

23 pha(-/-) mice exhibited significantly higher right ventricular systolic pressure compared with wild-t

24 sure cardiac parameters, including estimated right ventricular systolic pressure (ERVSP), and a full

25 In PPH patients, resting right ventricular systolic pressure fell after NO inhala

26 6.3 to 10.9 +/- 6.7 mm Hg (P<0.001), and the right ventricular systolic pressure fell from 71.6 +/- 2

27 of echocardiogram data, pHTN was defined as right ventricular systolic pressure greater than or equa

28 A subset of mice with right ventricular systolic pressure >30 mm Hg exhibited

29 In patients with an estimated right ventricular systolic pressure>35 mm Hg, suggestive

30 s score (hazard ratio 1.55), higher baseline right ventricular systolic pressure (hazard ratio 1.11),

31 dence interval, 0.17-0.50; P<0.001), resting right ventricular systolic pressure (hazard ratio, 1.03;

32 gurgitation (hazard ratio, 1.29), and higher right ventricular systolic pressure (hazard ratio, 1.3)

33 nuated the acute hypoxia-induced increase in right ventricular systolic pressure in anesthetized mice

34 cular lesions, fasudil also markedly reduced right ventricular systolic pressure in late-stage rats.

35 We observed a significant increase in right ventricular systolic pressure in Prkg1(-/-) mice i

36 Hypoxia caused similar increases in right ventricular systolic pressure in wild-type and HO-

37 pressing nuRFP alone) attenuated MCT-induced right ventricular systolic pressure increase, right vent

38 emia, medications, aortic regurgitation, and right ventricular systolic pressure), increased the c-st

39 eart catheterization in patients in whom the right ventricular systolic pressure is calculated to be

40 th pulmonary hypertension, but estimation of right ventricular systolic pressure is often inaccurate.

41 Controls had a right ventricular systolic pressure < 40 mm Hg (if estim

42 ios (Th1/Tc1) (P=0.009), while in those with right ventricular systolic pressure<35 mm Hg, a lower va

43 rols (normal echocardiography with estimated right ventricular systolic pressure, <35 mm Hg; n = 122)

44 t ventricular systolic pressure, peak stress right ventricular systolic pressure, metabolic equivalen

45 and MCT+AP rats developed PH with respective right ventricular systolic pressures of 40.2 +/- 1.5 and

46 onse to treatment at 6 months was defined by right ventricular systolic pressure or MPAP as significa

47 , indexed LV end-systolic dimension, resting right ventricular systolic pressure, peak stress right v

48 % O(2)) exhibited a significant reduction in right ventricular systolic pressure (placebo versus sild

49 lower LV ejection fraction, and high resting right ventricular systolic pressure predicted worse outc

50 iety of Thoracic Surgeons score and baseline right ventricular systolic pressure) provided incrementa

51 ressures (Ppa = 41 +/- 3 mm Hg) (p < 0.001), right ventricular systolic pressures (Prv,s = 45 +/- 2 m

52 on and remodeling, as evidenced by decreased right ventricular systolic pressure, ratio of right vent

53 e pulmonary hypertension, judged by elevated right ventricular systolic pressure, right ventricular h

54 nhibitor resulted in prevention of increased right ventricular systolic pressure, right ventricular h

55 ia-treated rats with established PH improved right ventricular systolic pressures, right ventricular

56 Right ventricular systolic pressure (RVSP) (mean +/- SD)

57 e wall curvature ratio for prediction of the right ventricular systolic pressure (RVSP) in patients c

58 The rise in right ventricular systolic pressure (RVSP) normally obse

59 lated altitude of 17,000 ft for 5 weeks, and right ventricular systolic pressure (RVSP) was measured.

60 ndexed LV end-systolic diameter (LVESD), and right ventricular systolic pressure (RVSP) were 62 +/- 2

61 mice were found to have the same life span, right ventricular systolic pressure (RVSP), and lung his

62 itral effective regurgitant orifice, resting right ventricular systolic pressure (RVSP), exercise met

63 Right ventricular systolic pressure (RVSP), RV weight, a

64 cardiac echocardiography and measurements of right ventricular systolic pressure (RVSP).

65 erwent Doppler echocardiography to determine right ventricular systolic pressure (RVSP).

66 nary hypertension (PHT) (RVEF 31.4 +/- 9.6%, right ventricular systolic pressure [RVSP] 76.5 +/- 26.2

67 y hypertension with exaggerated elevation of right ventricular systolic pressure, significant right v

68 In the lungs of these mice with high right ventricular systolic pressure, the expression of p

69 hypertension associated with an increase in right ventricular systolic pressure, thickening of the p

70 AP-Cav to MCT rats significantly reduced the right ventricular systolic pressure to 30.1 +/- 1.3 mm H

71 Preexercise right ventricular systolic pressure was assessed by Dopp

72 s score, degree of aortic regurgitation, and right ventricular systolic pressure) was 0.64 (95% confi

73 Society of Thoracic Surgeons score and right ventricular systolic pressure were 2+/-3 and 15+/-

74 The Society of Thoracic Surgeons score and right ventricular systolic pressure were 3.3+/-3 and 31+

75 rifice, indexed LV end-diastolic volume, and right ventricular systolic pressure were 4+/-1%, 62+/-3%

76 n fraction, mean aortic valve gradients, and right ventricular systolic pressure were 7+/-6, 58+/-6%,

77 determined that age, renal dysfunction, and right ventricular systolic pressure were independently a

78 Wide ranges of right ventricular systolic pressure were observed in mic

79 Despite higher right ventricular systolic pressures with chronic hypoxi